
CF AMR Syndicate
@cfamrsyndicate
In 2019 @MedDiscCat joined forces with @CFTrust and more recently @Lifearc1 to form the Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR).
ID: 1597202774638428167
https://cfamr.org.uk/ 28-11-2022 12:17:35
159 Tweet
82 Takipçi
56 Takip Edilen


We’re excited to announce Bicycle Therapeutics as part of the first cohort in our Collaborative Discovery Programme. They’re developing a new class of antibiotics targeting P. aeruginosa infections for CF-related lung issues. More details here: cfamr.org.uk/collaborative-…




📢 Next month, we’re speaking at the Faculty of Pharmaceutical Medicine Annual Symposium! We’ll share insights on our TPP development, collaborating with those with lived experience, and the impact on R&D. 🔗: fpm.org.uk/events/fpm-ann… LifeArc Medicines Discovery Catapult Cystic Fibrosis Trust


We’re delighted to announce another successful awardee from our CDP funding call. Rostra Therapeutics are looking to progress its novel programme aimed at targeting fungal infections in #CysticFibrosis. More here eu1.hubs.ly/H0dKqXq0 LifeArc | Cystic Fibrosis Trust | Medicines Discovery Catapult

🌕 In the lead-up to #WAAW next week, Aaron reminds us of the reality faced by some people living with #CysticFibrosis, highlighting why new treatments are still needed. Join us next week as we get behind this important campaign. eu1.hubs.ly/H0dMv2q0 World Health Organization (WHO) #WAAW24 #AMR





🌕 Fantastic day Faculty of Pharmaceutical Medicine's annual symposium. Great to have been part of the discussion on integrating lived experience early in product development and the impact of this approach on R&D efforts.


Rostra Therapeutics Chemistry - University of Strathclyde receives funding for #cysticfibrosis drug discovery from the CF Antimicrobial Resistance Syndicate Cystic Fibrosis Trust Medicines Discovery Catapult LifeArc bit.ly/3BdjXin





